Skip to main content
Promino Nutritional Sciences Inc. logo

Promino Nutritional Sciences Inc. — Investor Relations & Filings

Ticker · MUSL ISIN · CA74290V2049 CSE Manufacturing
Filings indexed 332 across all filing types
Latest filing 2022-11-29 Regulatory Filings
Country CA Canada
Listing CSE MUSL

About Promino Nutritional Sciences Inc.

https://drinkpromino.com/

Promino Nutritional Sciences Inc. is a research-driven nutraceutical company specializing in the development and distribution of science-based, clinically proven nutritional products for muscle health and recovery. The company focuses on patented formulations of essential amino acids (EAAs) designed to optimize muscle protein synthesis (MPS). Its flagship product, Promino™, is a consumer supplement that delivers a precise ratio and potency of all nine EAAs, demonstrated to be significantly more effective than traditional protein sources like whey. Promino's products target athletes and individuals seeking metabolic health improvements. The company also explores clinical applications, such as retaining muscle mass in cancer patients undergoing chemotherapy.

Recent filings

Filing Released Lang Actions
52-109FV2 - Certification of interim filings - CFO (E).pdf
Regulatory Filings Classification · 100% confidence The document is a FORM 52-109FV2 Certification of Interim Filings Venture Issuer Basic Certificate signed by the CFO. It certifies the review and fair presentation of the interim financial report and interim MD&A for the period ended September 30, 2022. The document is primarily an officer certification letter and does not contain actual financial data or the interim report itself. According to the CERTIFICATION RULE, such certification documents should be classified as Regulatory Filings (RNS) rather than as the interim report (IR). The document length is short (3013 characters) and it is a certification, not the report itself.
2022-11-29 English
52-109FV2 - Certification of interim filings - CEO (E).pdf
Regulatory Filings Classification · 100% confidence The document is a certification letter titled 'FORM 52-109FV2 CERTIFICATION OF INTERIM FILINGS VENTURE ISSUER BASIC CERTIFICATE' signed by the CEO certifying the review and fair presentation of the interim financial report and interim MD&A for the period ended September 30, 2022. It explicitly states it is a certification of interim filings, not the filings themselves. The document is short (3022 characters) and primarily an officer attestation without substantive financial data or analysis. According to the Certification Rule, such documents should be classified as Regulatory Filings (RNS) rather than as an Interim Report (IR).
2022-11-29 English
Notice of the meeting and record date - English.pdf
AGM Information Classification · 95% confidence The document is a notice regarding the upcoming Annual General Meeting (AGM) of Element Nutritional Sciences Inc., specifying meeting type, record dates, meeting date, location, and voting securities details. It does not contain any financial data, management discussion, or detailed report content. The document is short (1181 characters) and serves as an announcement about the meeting and record dates rather than the AGM materials themselves. Therefore, it fits the category of AGM Information (AGM-R), which covers presentations and materials shared during the AGM or related notices about the AGM.
2022-11-21 English
News release - English.pdf
Regulatory Filings
2022-11-07 English
News release - English.pdf
Regulatory Filings
2022-10-17 English
News release - English.pdf
Regulatory Filings
2022-10-17 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.